| Trial ID: | L3192 |
| Source ID: | NCT02143765
|
| Associated Drug: |
Mitiglinide
|
| Title: |
Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
Match-101
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Mitiglinide|DRUG: Acarbose
|
| Outcome Measures: |
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 12, Baseline and Week 12 | Secondary: the change from baseline to the end of treatment in fasting blood glucose (FBG), postprandial blood glucose (PBG), Baseline, 4 weeks, 8 weeks, 12 weeks|Number of Participants with Serious and Non-Serious Adverse Events, Adverse events will be collected and followed in order to evaluate safety and tolerability, up to 12 weeks|the change from baseline to the end of treatment in Diabetes Quality of Life, measured by Diabetes specific Quality of Life scale (DSQL) at baseline and 12 weeks, baseline and 12 weeks|Treatment compliance, up to 12 weeks|Diabetes Treatment Satisfaction, measured by Diabetes Treatment Satisfaction Questionnaire (DTSQs) at 12 weeks, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Zhongda Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
248
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-05
|
| Completion Date: |
2015-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-07-14
|
| Locations: |
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China|The Second People's Hospital of Huai'an, Huai'an, Jiangsu, China|Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University, Nanjing, Jiangsu, China|Xuzhou Central Hospital, Xuzhou, Jiangsu, China|Yancheng City No.1 People's Hospital, Yancheng, Jiangsu, China|Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02143765
|
